Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 AUD | -1.64% | -7.69% | +46.34% |
Mar. 12 | Dimerix Raises AU$20 Million for Kidney Disease Study | MT |
Mar. 11 | Dimerix Expanding Kidney Drug Study After DMX-200 Performs Better than Placebo | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+46.34% | 109M | |
+8.96% | 45.97B | |
+52.45% | 43.93B | |
+8.08% | 42.34B | |
-8.78% | 28.27B | |
+17.89% | 27.18B | |
-20.86% | 19.44B | |
+14.37% | 13.83B | |
+31.88% | 12.4B | |
+9.95% | 11.45B |
- Stock
- Equities
- Stock Dimerix Limited - Australian S.E.
- News Dimerix Limited
- Dimerix : Expands Phase 3 Study for COVID-19 Drug to Australia; Shares Rise 4%